Marc Odrich
CIK: 0002015900
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LENZ Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 2, 2026LENZ
LENZ Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
84.2K shares- - Jan 2, 2026LENZ
LENZ Therapeutics, Inc.
Award(A)DirectRestricted Stock Unit
14K shares- - Jan 9, 2025LENZ
LENZ Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
80.1K shares-
1-3 of 3 transactions
About Odrich Marc
Odrich Marc (SEC CIK 0002015900) files insider reports with the SEC as Chief Medical Officer of LENZ Therapeutics, Inc. (LENZ).
Signal8 holds 2 ownership filings by Odrich Marc, all Form 4s, filed between Jan 13, 2025 and Jan 6, 2026. Those filings report 3 transactions, from Jan 9, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Odrich Marc's filings is in SOLANA BEACH, CA.
Recent filings by Odrich Marc
Other insiders filing for LENZ Therapeutics, Inc. (LENZ)
- Chevallard Daniel R., Chief Financial Officer
- RA CAPITAL MANAGEMENT, L.P., 10% Owner
- George Jeffrey P., Director
- Drapkin Kimberlee C, Director
- MCCOLLUM JAMES W, Director
- Thunen Shelley B, Director